Senior Principal Data Scientist
F. Hoffmann-La Roche Ltd, Switzerland
Thibaut Sanglier is a pharmacoepidemiologist working as a Senior Principal Data Scientist in the Real World Data Sciences group at F. Hoffmann-La Roche. His main focus is on leveraging Real-World Data (RWD) to achieve the following objectives:
1) Accelerating the development of drugs for HER2+ breast cancer treatment.
2) Studying the safety and effectiveness of HER2 targeted therapies.
3) Improving patients' access to HER2 targeted therapies.
In his role, Thibaut Sanglier contributes to the use of RWD to drive advancements in the field of HER2+ breast cancer treatment and promote evidence-based decision-making for the benefit of patients.
